As the global economy mends, the 2021 growth of Subcutaneous Medicine Delivery Devices will have significant change from previous year. According to our (LP Information) latest study, the global Subcutaneous Medicine Delivery Devices market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Subcutaneous Medicine Delivery Devices market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Subcutaneous Medicine Delivery Devices market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Subcutaneous Medicine Delivery Devices market, reaching US$ million by the year 2028. As for the Europe Subcutaneous Medicine Delivery Devices landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Subcutaneous Medicine Delivery Devices players cover Boehringer Ingelheim, Eli Lily, Galaxo, and HMD pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Medicine Delivery Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Implantable Subcutaneous Medicine Delivery Device
Injection Type Subcutaneous Medicine Delivery Device
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Boehringer Ingelheim
Eli Lily
Galaxo
HMD pharmaceuticals
Merck
Novartis
Novo Nordisk
Pfizer
Sanofi
Teva Pharmaceutical
Zogenix
BD
Insulet Corporation
Enable Injections
West Pharmaceutical Services
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier